Moreover, the risk of atherosclerosis showed a dose-dependent relationship in Hp (−) NAFLD/MAFLD and Hp (±) NAFLD/MAFLD [OR (95% CI), 1.61 (1.15–2.26) and 1.80 (1.36–2.39) in Hp (−) NAFLD/MAFLD vs. 2.23 (1.63–3.06) and 2.13 (1.64–2.78) in Hp (±) NAFLD/MAFLD, respectively]. The gene discussed is HP; the disease is metabolic dysfunction-associated steatotic liver disease.